Pan-Cancer Survival Impact of Immune Checkpoint Inhibitors in a National Healthcare System.
Miller SR, Schipper M, Fritsche LG, Jiang R, Strohbehn G, Ötleş E, McMahon BH, Crivelli S, Zamora-Resendiz R, Ramnath N, Yoo S, Dai X, Sankar K, Edwards DM, Allen SG, Green MD, Bryant AK.
Miller SR, et al. Among authors: allen sg.
Cancer Med. 2024 Nov;13(21):e70379. doi: 10.1002/cam4.70379.
Cancer Med. 2024.
PMID: 39508134
Free PMC article.